Sema4|GeneDx to Participate in the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Sema4 (Nasdaq: SMFR) has announced its participation in the 41st Annual J.P. Morgan Healthcare Conference, taking place in San Francisco. The company's President & CEO, Katherine Stueland, will make a presentation on January 12, 2023, at 10:30 a.m. PT. Interested parties can access a live and archived webcast of the event via the Sema4 investor relations website. Sema4 is focused on leveraging AI and machine learning to enhance healthcare by providing data-driven insights through its innovative platform, Centrellis.

Sema4|GeneDx President & Chief Executive Officer, Katherine Stueland, to deliver presentation

STAMFORD, Conn., Dec. 30, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced the company will participate in the 41^st Annual J.P. Morgan Healthcare Conference in San Francisco. Katherine Stueland, President and Chief Executive Officer, will deliver a formal presentation on Thursday, January 12, 2023, at 10:30 a.m. PT.

A live and archived webcast of the presentation will be available on the “Events” section of the Sema4|GeneDx investor relations website at https://ir.sema4.com/.

About Sema4|GeneDx

Sema4|GeneDx is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis®, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.

For more information, please visit sema4.com and connect with Sema4 on Twitter, LinkedIn, Facebook and YouTube.

Contact:
Tricia Truehart
Investor Relations
investors@sema4.com

FAQ

What date is Sema4's presentation at the J.P. Morgan Healthcare Conference?

Sema4's presentation is scheduled for January 12, 2023.

Who is presenting for Sema4 at the conference?

Katherine Stueland, President and CEO of Sema4, will deliver the presentation.

What time will the Sema4 presentation take place?

The presentation will occur at 10:30 a.m. PT.

How can I watch Sema4's presentation?

You can watch the presentation live or access the archived version on the Sema4 investor relations website.

What is Sema4's stock symbol?

Sema4's stock symbols are SMFR and SMFRW.